Join
Live feed
·
PRReleasevia Quantisnow
KALA BIO Inc. logo

Kala Pharmaceuticals Announces Distribution of Series D Preferred Stock to Holders of its Common Stock

ByQuantisnow·Wall Street's wire, on your screen.
KALA· KALA BIO Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KALA (KALA BIO Inc.) and more on Quantisnow.